These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34751112)

  • 41. MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications.
    Strubberg AM; Madison BB
    Dis Model Mech; 2017 Mar; 10(3):197-214. PubMed ID: 28250048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of miRNA in cancer diagnosis, prognosis, therapy and regulation of its expression by Epstein-Barr virus and human papillomaviruses: With special reference to oral cancer.
    Chawla JP; Iyer N; Soodan KS; Sharma A; Khurana SK; Priyadarshni P
    Oral Oncol; 2015 Aug; 51(8):731-7. PubMed ID: 26093389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. microRNAs and lung cancer: tumors and 22-mers.
    Du L; Pertsemlidis A
    Cancer Metastasis Rev; 2010 Mar; 29(1):109-22. PubMed ID: 20130964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential.
    Kashyap D; Tuli HS; Garg VK; Goel N; Bishayee A
    Mol Diagn Ther; 2018 Apr; 22(2):179-201. PubMed ID: 29388067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone Metastasis-Related MicroRNAs: New Targets for Treatment?
    Zhao Q; Luo F; Ma J; Yu X
    Curr Cancer Drug Targets; 2015; 15(8):716-25. PubMed ID: 26119014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-143 as a new weapon against cancer: overview of the mechanistic insights and long non-coding RNA mediated regulation of miRNA-143 in different cancers.
    Farooqi AA; Qureshi MZ; Attar R; Alhewairini SS; Fayyaz S; Sabitaliyevich UY; Duisenbayevich TM; Alaaeddine N
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):1-5. PubMed ID: 31472055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exploring miRNA based approaches in cancer diagnostics and therapeutics.
    Mishra S; Yadav T; Rani V
    Crit Rev Oncol Hematol; 2016 Feb; 98():12-23. PubMed ID: 26481951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo delivery of miRNAs for cancer therapy: challenges and strategies.
    Chen Y; Gao DY; Huang L
    Adv Drug Deliv Rev; 2015 Jan; 81():128-41. PubMed ID: 24859533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross talk between microRNA and coding cancer genes.
    Kunej T; Godnic I; Horvat S; Zorc M; Calin GA
    Cancer J; 2012; 18(3):223-31. PubMed ID: 22647358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
    Kent OA; Mendell JT
    Oncogene; 2006 Oct; 25(46):6188-96. PubMed ID: 17028598
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments.
    To KKW; Fong W; Tong CWS; Wu M; Yan W; Cho WCS
    Expert Opin Drug Discov; 2020 Jan; 15(1):63-83. PubMed ID: 31739699
    [No Abstract]   [Full Text] [Related]  

  • 52. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
    Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A minor review of microRNA-338 exploring the insights of its function in tumorigenesis.
    Yi Q; Cui H; Liao Y; Xiong J; Ye X; Sun W
    Biomed Pharmacother; 2021 Jul; 139():111720. PubMed ID: 34243620
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comprehensive review on oncogenic miRNAs in breast cancer.
    Maryam M; Naemi M; Hasani SS
    J Genet; 2021; 100():. PubMed ID: 33764337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent trends in targeting miRNAs for cancer therapy.
    Shah V; Shah J
    J Pharm Pharmacol; 2020 Dec; 72(12):1732-1749. PubMed ID: 32783235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Emerging Role of MicroRNAs in Breast Cancer.
    Yang Z; Liu Z
    J Oncol; 2020; 2020():9160905. PubMed ID: 32714393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer.
    Jafri MA; Zaidi SK; Ansari SA; Al-Qahtani MH; Shay JW
    Expert Opin Ther Targets; 2015; 19(12):1705-23. PubMed ID: 26189482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies.
    Forterre A; Komuro H; Aminova S; Harada M
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32660045
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of microRNAs in lung cancer progression.
    Zhang WC; Liu J; Xu X; Wang G
    Med Oncol; 2013; 30(3):675. PubMed ID: 23925663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment.
    Kaboli PJ; Rahmat A; Ismail P; Ling KH
    Pharmacol Res; 2015 Jul; 97():104-21. PubMed ID: 25958353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.